Dr. Anthony Kuhlmann, of counsel in the Orange County office, is a member of the Intellectual Property Group.

Anthony is a registered patent attorney concentrating his practice in the area of patent prosecution and strategic client counseling in the life sciences with particular experience in biotechnology, pharmaceuticals and medical diagnostics.

Anthony has an in-depth understanding of drug development, research and toxicology, as well as in the development of medical diagnostics. He uses this unique skill set to advise in-house counsel and company executives on the development of worldwide patent portfolios and the integration of intellectual property and business assets.

Anthony's experience also includes conducting IP due diligence for corporate transactions and acquisitions, negotiating licensing agreements, performing patentability, infringement and validity analyses, and authoring opinion letters.

Prior to law school, Anthony was an investigator for Vertex Pharmaceuticals, Inc., where he established an animal model of Parkinson's disease for efficacy and toxicity studies. He has co-authored numerous scientific publications in the fields of neurotoxicology and neuropathology. His publications appear in journals including Journal of Neurochemistry, Neuroscience Letters, Brain Research and Toxicological Sciences.